Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

This comprehensive volume, with contributions from leading experts, provides a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. The volume addresses: understanding lung cancer – statistics and epidemiology of lung cancer, along with the incidence of lung cancer in non-smokers; state of current therapies–immune, targeted therapies against EGFR TKIs, KRAS, ALK and the associated challenges, especially resistance mechanisms; recent progress in targeted drug development based on metal chemistry and genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy for lung cancer patients.

• ISBN: 978-3-319-24931-5
• Editorial: Springer
• Encuadernacion: Cartoné
• Fecha Publicación: 17/04/2016
• Nº Volúmenes: 1
• Idioma: Inglés